Gadobenate dimeglumine

钆贝葡胺

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameGadobenate dimeglumine
Drug Alias Namegadobenic acid dimeglumine saltMultiHanceE-7155B-19036/7
ClassificationSmall moleculesDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsContrast agentsPeripheral Vascular DiseasesVascular Diseases +[6] 
Global Approved IndicationsContrast agentsCentral Nervous System Diseases
Approved Indications in ChinaContrast agents
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1998/03/11
Country/TerritoryUnited StatesPolandItaly +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBracco Spa
China Registration ClassN/A

Develop Information

Active CompaniesBracco SpaUniversity Of Wisconsin-Madison
Inactive CompaniesBracco Diagnostics Inc
Active IndicationsContrast agentsCentral Nervous System DiseasesBreast Neoplasms +[4] 
Inactive IndicationsPeripheral Vascular DiseasesVascular Diseases

Other Information

ATC CodeV08CA08
Related LinksWikipediaDrugBankKEGG